Skip to content

New head of Cushman & Wakefield’s EMEA corporate finance team

At Cushman & Wakefield, as an integral part of the Firm's global capital markets platform, Michael will develop and further expand its existing capabilities in the area of work out, restructuring and recovery of distressed commercial real estate loans and assets across EMEA.

Prior to joining Cushman & Wakefield, Michael held various senior appointments including Partner and UK Head of Corporate Finance at KPMG LLP and Director in Citigroup's Real Estate & Lodging Investment Banking team.

Michael has worked in real estate corporate finance since 1998 and his experience includes debt and equity advisory, corporate real estate solutions, M&A, loan sales and restructuring/insolvency. Whilst at KPMG where he was a Partner since 2005, he recently led a team advising the liquidators of a Lehman subsidiary in Asia on the management and realisation of a €1.2 billion real estate loan portfolio secured on assets in China, Thailand and Malaysia.

Greg Vorwaller, Global Head of Cushman & Wakefield Capital Markets said: "Michael will strengthen our team and enable us to meet the growth in demand for our loan work out and distressed asset services from institutions, owners and investors who are today facing challenges of maturing debt, complex capital structures and under-performing assets. The depth of experience he will bring to the role will further enhance our position as a leading advisor in the real estate finance arena both in EMEA and globally in line with our strategic growth plan."

Michael Lindsay will join Matthew Stone and Luca Giangolini and run the EMEA Corporate Finance team which comprises chartered accountants, corporate financiers, surveyors and financial analysts. The team's recent successes include a substantial international equity raise for L&G's UK Property Income Fund and the disposal of 177 surplus leasehold liabilities for Wolseley in a single transaction.

This latest appointment is part of an ongoing strategic recruitment initiative across Cushman & Wakefield.